| HGNC Family | Non-coding RNAs |
| Name | microRNA 208b |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR‐208b, an evolutionarily conserved cardiac‐enriched microRNA, has emerged as a promising circulating biomarker in cardiovascular diseases. Several studies have demonstrated that altered levels of miR‐208b in plasma can aid in the early diagnosis of acute myocardial infarction and acute coronary syndrome, with its expression changes correlating with adverse clinical outcomes. These findings highlight its diagnostic and prognostic potential as a minimally invasive biomarker in the evaluation of cardiac pathology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its utility as a biomarker, miR‐208b directly contributes to cardiac remodeling. In chronic atrial fibrillation, upregulated miR‐208b expression in atrial myocytes has been shown to impair calcium handling by downregulating key components—including L‐type Ca²⁺ channel subunits and the sarcoplasmic reticulum Ca²⁺ pump—thus promoting both electrical and structural remodeling of the atria."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond cardiovascular disorders, miR‐208b plays a role in the host response to viral infection. In hepatitis C virus–infected hepatocytes, aberrant upregulation of miR‐208b (alongside miR‐499a-5p) suppresses the antiviral interferon response by directly downregulating type I interferon receptor subunit IFNAR1. This modulation of interferon signaling aids in viral persistence by dampening both type I and type III interferon pathways."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nmiR‐208b also exerts diverse functions in oncogenesis. In colorectal cancer, tumor cells secrete miR‐208b via exosomes, which—upon uptake by regulatory T cells—targets PDCD4 to promote Treg expansion, contributing to chemoresistance against oxaliplatin-based regimens. Conversely, studies in osteosarcoma indicate that overexpression of miR‐208b suppresses tumor cell proliferation and migration by targeting receptor tyrosine kinase‐like orphan receptor 2, suggesting a tumor‐suppressive role in this context."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCirculating expression levels of miR‐208b have also been associated with endothelial dysfunction in patients with essential hypertension, with a strong correlation observed between miR‐208b levels in peripheral blood mononuclear cells and urinary albumin excretion—a recognized early marker of vascular damage."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, in the setting of familial hypertrophic cardiomyopathy, patients carrying MYBPC3 mutations exhibit a specific upregulation of miR‐208b-3p. This overexpression is linked to the activation of the canonical Wnt signaling pathway through its regulation of target genes involved in cardiac muscle gene programming, thereby contributing to myocardial hypertrophy and adverse remodeling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Maarten F Corsten, Robert Dennert, Sylvia Jochems, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Cardiovasc Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCGENETICS.110.957415"}], "href": "https://doi.org/10.1161/CIRCGENETICS.110.957415"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20921333"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20921333"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Olof Gidlöf, J Gustav Smith, Kazuma Miyazu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cardiovasc Disord (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2261-13-12"}], "href": "https://doi.org/10.1186/1471-2261-13-12"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23448306"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23448306"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yu Kakimoto, Hiroshi Kamiguchi, Eriko Ochiai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA Stability in Postmortem FFPE Tissues: Quantitative Analysis Using Autoptic Samples from Acute Myocardial Infarction Patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0129338"}], "href": "https://doi.org/10.1371/journal.pone.0129338"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26046358"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26046358"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Konstantinos Agiannitopoulos, Panagiota Pavlopoulou, Konstantinos Tsamis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of miR-208b and miR-499 in Greek Patients with Acute Myocardial Infarction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "In Vivo (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.21873/invivo.11239"}], "href": "https://doi.org/10.21873/invivo.11239"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29475914"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29475914"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Xiaoxiao Liu, Ling Yuan, Fang Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating miR-208b: A Potentially Sensitive and Reliable Biomarker for the Diagnosis and Prognosis of Acute Myocardial Infarction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Lab (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7754/Clin.Lab.2016.160632"}], "href": "https://doi.org/10.7754/Clin.Lab.2016.160632"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28164501"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28164501"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Mostafa Alavi-Moghaddam, Mohammad Chehrazi, Shamila D Alipoor, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Preliminary Study of microRNA-208b after Acute Myocardial Infarction: Impact on 6-Month Survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dis Markers (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2018/2410451"}], "href": "https://doi.org/10.1155/2018/2410451"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29977411"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29977411"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Wei Wang, Tai Li, Lei Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma miR-208b and miR-499: Potential Biomarkers for Severity of Coronary Artery Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dis Markers (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2019/9842427"}], "href": "https://doi.org/10.1155/2019/9842427"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31885748"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31885748"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Wei Wang, Tai Li, Lei Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diagnostic and prognostic impact of circulating microRNA-208b and microRNA-499 in patients with acute coronary syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomark Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/bmm-2019-0257"}], "href": "https://doi.org/10.2217/bmm-2019-0257"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31789049"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31789049"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Susana Cañón, Ricardo Caballero, Adela Herraiz-Martínez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-208b upregulation interferes with calcium handling in HL-1 atrial myocytes: Implications in human chronic atrial fibrillation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Cell Cardiol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yjmcc.2016.08.012"}], "href": "https://doi.org/10.1016/j.yjmcc.2016.08.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27545043"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27545043"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Abigail Jarret, Adelle P McFarland, Stacy M Horner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.4211"}], "href": "https://doi.org/10.1038/nm.4211"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27841874"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27841874"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Tao Ning, Jialu Li, Yi He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Ther (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ymthe.2021.04.028"}], "href": "https://doi.org/10.1016/j.ymthe.2021.04.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33905821"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33905821"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Zhe Jiang, Chunshan Jiang, Chonglong Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-208b inhibits human osteosarcoma progression by targeting ROR2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1010428317705751"}], "href": "https://doi.org/10.1177/1010428317705751"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28618961"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28618961"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "F I Parthenakis, M E Marketou, J E Kontaraki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comparative microRNA profiling in relation to urinary albumin excretion in newly diagnosed hypertensive patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hum Hypertens (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/jhh.2016.15"}], "href": "https://doi.org/10.1038/jhh.2016.15"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26984682"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26984682"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Li-Rong Lin, Xue-Qun Hu, Li-Hong Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cardiovasc Disord (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12872-022-02714-6"}], "href": "https://doi.org/10.1186/s12872-022-02714-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35717150"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35717150"}]}]}]}
|
| Synonyms | MIRN208B, MIR-208B |
| NCBI Gene ID | 100126336 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR208B has 294 functional associations with biological entities spanning 5 categories (molecular profile, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 15 datasets.
Click the + buttons to view associations for MIR208B from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR208B gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR208B gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR208B gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR208B gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR208B gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR208B gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR208B gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR208B gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MIR208B gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR208B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR208B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR208B gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MIR208B gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR208B gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by MIR208B gene mutations from the MPO Gene-Phenotype Associations dataset. | |